Inductive Bio

Inductive has career opportunities related to AI-integrated chemistry and drug discovery.

The team includes medicinal chemists, computational scientists, and drug hunters building a chemical intelligence organization for drug discovery.

The company offers AI solutions for small molecule drug discovery, including AI-integrated synthesis, a virtual lab bench, ADME assays, and embedded chemistry experts.

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio launch ADME-One, a co-developed high-throughput Tier 1 ADME panel. The platform combines AI-driven human PK projection with integrated compound management.

May 2026 · Inductive BioNews article

Inductive Bio receives an award of up to $21 million from ARPA-H’s CATALYST program to lead DATAMAP, a project developing AI drug-toxicity models using organoids and human model systems. The company works with Amgen, Cincinnati Children’s, Baylor, and Torch Bio on models intended to improve drug safety assessment.

Dec 2025 · Inductive BioNews article

Inductive Bio raises $25 million in Series A financing led by Obvious Ventures. The company plans to use the funding to expand its AI model research, grow its pre-competitive data consortium, and deploy its Compass ADMET platform industry-wide for small-molecule drug discovery.

May 2025 · Inductive BioNews article

Inductive Bio and Nested Therapeutics publish their drug optimization collaboration in ACS Medicinal Chemistry Letters. The publication reports that the collaboration’s use of ADMET models paired with potency predictions reduces the number of compounds synthesized and accelerates its lead-optimization process.

Sep 2024 · Inductive BioNews article